Sign In

Morgan Moncada

MBA/MS Biotech Candidate at Harvard - VP Ops, Co-MD Boston Chapter at Nucleate - Longevity, SynBio, Data Science - Stanford alum

Morgan Moncada is a notable figure in the health technology sector, currently serving as the Co-Managing Director for the Boston branch and Vice President of Operations at Nucleate. She is also recognized as the CEO and co-founder of Willow Health, an AI platform focused on holistic brain health monitoring and intervention. Moncada's expertise lies in integrating artificial intelligence with healthcare solutions, which is reflected in her leadership roles and entrepreneurial ventures.

She recently gained recognition as a 2023-2024 Blavatnik Fellow at Harvard Business School, a program designed to support entrepreneurs in the life sciences field. This fellowship allows participants to develop new ventures around promising life science technologies while receiving mentorship and professional development opportunities.12 Moncada holds a strong educational background, having completed her MS/MBA at Harvard Business School and a Bachelor's degree in Biology from Stanford University.

Her professional journey highlights her commitment to advancing health technology and her role in shaping future innovations in the biomedical industry.

Highlights

Aug 23 · linkedin

Did you know that sleep disorders affect 1 in 5 people, costing the US economy a staggering $411 billion annually? Let's break down the numbers:

🔍 The Scale of the Sleep Crisis:

  • 70 million Americans suffer from chronic sleep issues
  • 80% of sleep apnea patients remain undiagnosed
  • 60% higher healthcare spend for those with chronic sleep disorders

👩‍⚕️ The Most Affected:

  • 20+ million shift workers, including first responders, healthcare professionals, and transportation workers
  • 50% of shift workers experience insomnia, sleep apnea, or shift work sleep disorder

💼 The Cost to Employers:

  • $136 billion in annual costs due to lost productivity and accidents
  • The trucking industry alone faces $20 billion yearly in accidents, 70% from drowsy driving

🏥 The Health Impact: Sleep disorders are linked to higher rates of depression, diabetes, hypertension, dementia, and even cancer. Research is increasingly showing that sleep is a direct factor causing these diseases.

🚧 The Challenges:

  • Long wait times for sleep care
  • Shortage of healthcare providers and specialists
  • 50% of sleep apnea patients struggle with treatment adherence

At Neru Health, we're tackling this crisis head-on. Our mission: to scale sleep care, improving provider operations and patient outcomes through personalized, affordable, and continuous care.

👉 Join Us in Transforming Sleep Health:

  • Connect with us: Follow our page for sleep health insights
  • Connect us: We're seeking partnerships with sleep clinics, DME leaders, digital health innovators, and employers
  • Share your expertise: Let's collaborate!

Together, we can improve the quality of life for millions in America and billions worldwide. Let's connect and make a difference!

#SleepHealth #NeruHealth #HealthcareInnovation #AIinHealthcare #DigitalHealth #Wellness #patientadherence

Related Questions

What is Morgan Moncada's role at Nucleate?
How did Morgan Moncada transition from Harvard Business School to her current position?
What are some of Morgan Moncada's notable achievements in the healthtech industry?
What is the focus of Morgan Moncada's work at Willow Health?
How has Morgan Moncada's experience at Moderna influenced her career?
Morgan Moncada
Morgan Moncada, photo 1
Morgan Moncada, photo 2
Add to my network

Location

San Francisco Bay Area